Could my doctor be missing a treatment option for my cancer?
The short answer
Standard of care is a well-tested starting point, not a ceiling. Options get overlooked when biomarker testing is incomplete, when clinical trials are not discussed, when a subspecialist would treat the case differently, or when newer and off-label approaches are not raised. Checking systematically is worth the effort.
Ask Navis about your situation
This answer is general. Get one about your specific case. No signup, answered right here.
Who this applies to
Anyone whose plan feels one-size-fits-all, whose cancer is rare or advanced, or who wants to be sure the recommended treatment is the best fit and not just the default. Asking is not second-guessing your doctor; it is what an informed patient does.
Why options get missed
A busy oncologist works from standard pathways, which are right for most patients most of the time. Options slip through when the inputs are incomplete: biomarker testing that was never done, so a targeted therapy stays invisible; a clinical trial that was not searched for; a subspecialty center that would approach a rare cancer differently; or a newer or off-label option that has not reached routine practice. None of these means your doctor made a mistake. They mean the full option set is worth confirming.
Where to look
Four places account for most missed options. Biomarkers: confirm your tumor's full molecular profile has been tested, since that is what unlocks targeted therapies and many trials. Clinical trials: ask specifically whether any match your case, because trials are matched by type, stage, biomarkers, and prior treatment, not searched by default. A second opinion at a specialty center: subspecialists who see your exact cancer all day sometimes treat it differently. Newer and off-label approaches: for advanced disease, ask whether any recently approved or off-label option, or expanded access to an investigational drug, could apply.
Questions to ask your oncologist
- Have we considered every standard treatment option, and why is this one the best fit for me?
- Are there clinical trials I might qualify for given my biomarkers and prior treatment?
- Would a specialist center that focuses on my exact cancer approach this differently?
- Are there newer, off-label, or expanded-access options worth considering for my case?
Check this against your case
Upload your records and OpenCancer reads them against the guideline options for your exact diagnosis and biomarkers, then flags treatment options that are not yet on your plan, so you can ask about them directly.
Upload your records, freeSources & medical oversight
Written by OpenCancer’s science team and grounded in NCCN and NCI guidance. Independent medical review by our clinical team is in progress.
For informational purposes only. This page is grounded in published guidelines and is not medical advice. Always consult your oncologist or care team before making treatment decisions.